These newly recognized cancer-specific proteins, or antigens, could speed the development of potent immunotherapies that recognize and attack hard-to-treat tumors. The study, which was supported ...

The paper is titled "Neoself-antigens are the primary target for autoreactive T cells in human lupus." Autoimmune diseases develop when the body's immune system mistakenly attacks its own tissues ...

The initiation of T-cell–mediated antitumor immune responses requires the uptake and processing of tumor antigens by dendritic cells and their presentation on MHC-I molecules. Here we show in a ...

Scientists have discovered that psychological stress can induce immune responses to food that can cause symptoms when that ...

What makes your blood different from someone else’s is your unique combination of protein molecules, called antigens and antibodies. Antigens live on the surface of your red blood cells.

Epitopea Ltd. has signed a license and research collaboration agreement with MSD (Merck & Co. Inc.) to identify Cryptigen tumor-specific antigens in an undisclosed solid tumor. Cryptigen TSAs are ...

Boehringer Ingelheim has signed a strategic collaboration with UK biotech Enara Bio, focused on finding ways to fight cancer using “dark antigens” in a deal worth up to €876 million ($1.07bn).

Blood type can also affect the risk of developing blood clots. People with type A, B, or AB blood are more likely to ...

The following is a summary of "Impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced ...

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret antigens that could form the backbone of off-the-shelf immunotherapies.